In recent months, the change in the leadership of the IDIBAPS Clinical addictions group has been approved. Hugo López-Pelayo, takes over as head of the group, replacing Antoni Gual.
Gual has handed over the leadership of the research group due to his retirement, but remains linked to the Institute as emeritus researcher.
